ロード中...
Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation
Renal interstitial fibrosis is a common pathological feature in progressive kidney diseases currently lacking effective treatment. Nicotinamide (NAM), a member of water‐soluble vitamin B family, was recently suggested to have a therapeutic potential for acute kidney injury (AKI) in mice and humans....
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533567/ https://ncbi.nlm.nih.gov/pubmed/30993884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14285 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|